| Trial ID: | L0290 |
| Source ID: | NCT01318967
|
| Associated Drug: |
Furosemide
|
| Title: |
Measurement of Kidney Blood Flow and Oxygen Levels by MRI
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01318967/results
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Furosemide|OTHER: Placebo
|
| Outcome Measures: |
Primary: Measurement of Renal Blood Flow of the Kidney by the PAH Method, Renal blood flow is estimated by the PAH method., Renal blood flow is estimated over 1 hour by PAH | Secondary: Measurement of Regional Blood Oxygenation by MRI, Estimate of renal blood flow by using MRI scans before and after the administration of furosemide, One measure after furosemide (day 1)
|
| Sponsor/Collaborators: |
Sponsor: Wake Forest University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2010-10
|
| Completion Date: |
2013-06
|
| Results First Posted: |
2015-04-10
|
| Last Update Posted: |
2018-09-07
|
| Locations: |
Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01318967
|
